Keywords
Last Name
Institution

Robert E. Notari

Title
InstitutionMedical University of South Carolina
DepartmentSCCP Drug Discovery and Biomedical Sciences - MUSC Campus
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Dyar SC, Notari RE. A nomogram to evaluate intrinsic absorption rate constants of potential oral prolonged-release candidates. Pharm Dev Technol. 1999 Aug; 4(3):305-12. PMID: 10434276.
      View in: PubMed
    2. Fubara JO, Notari RE. Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions. J Pharm Sci. 1998 Dec; 87(12):1572-6. PMID: 10189269.
      View in: PubMed
    3. Fubara JO, Notari RE. A kinetic oxymoron: concentration-dependent first-order rate constants for hydrolysis of ceftazidime. J Pharm Sci. 1998 Jan; 87(1):53-8. PMID: 9452968.
      View in: PubMed
    4. Zhou M, Notari RE. A nomogram to predict the best biological half-life values for candidates for oral prolonged-release formulations. J Pharm Sci. 1996 Aug; 85(8):791-5. PMID: 8863265.
      View in: PubMed
    5. Zhou M, Notari RE. Methodology for using oral dose pharmacokinetic data to select drugs for prolonged release formulations and validation of the method using simulated data. Biopharm Drug Dispos. 1995 May; 16(4):319-31. PMID: 7548781.
      View in: PubMed
    6. Zhou M, Notari RE. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions. J Pharm Sci. 1995 May; 84(5):534-8. PMID: 7658340.
      View in: PubMed
    7. Wang D, Notari RE. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution. J Pharm Sci. 1994 Apr; 83(4):577-81. PMID: 8046618.
      View in: PubMed
    8. Lam CF, Jiang Q, Notari RE. An efficient method for computer-aided dosage form design. Comput Biol Med. 1993 Nov; 23(6):475-82. PMID: 8306626.
      View in: PubMed
    9. Irvin JR, Notari RE. Computer-aided dosage form design. III. Feasibility assessment for an oral prolonged-release phenytoin product. Pharm Res. 1991 Feb; 8(2):232-7. PMID: 2023873.
      View in: PubMed
    10. Nguyen NA, Notari RE. Substituent effects on degradation rates and pathways of cytosine nucleosides. J Pharm Sci. 1989 Oct; 78(10):802-6. PMID: 2600783.
      View in: PubMed
    11. Pfeifer RW, Notari RE. Predicting caffeine plasma concentrations resulting from consumption of food or beverages: a simple method and its origin. Drug Intell Clin Pharm. 1988 Dec; 22(12):953-9. PMID: 3243174.
      View in: PubMed
    12. Nguyen NA, Notari RE. Potential improvement in shelf life using the prodrug approach. II. A systematic examination of kinetic requirements. Pharm Res. 1988 Oct; 5(10):634-8. PMID: 3244615.
      View in: PubMed
    13. Nguyen NA, Mortada LM, Notari RE. Potential improvement in the shelf life of parenterals using the prodrug approach: bacampicillin and talampicillin hydrolysis kinetics and utilization time. Pharm Res. 1988 May; 5(5):288-96. PMID: 3244638.
      View in: PubMed
    14. Lee TY, Notari RE. Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility. Pharm Res. 1987 Oct; 4(5):385-91. PMID: 3508547.
      View in: PubMed
    15. Lee TY, Notari RE. Computer-aided dosage form design. I. Methods for defining a long-acting first-order delivery system of maximum formulating flexibility. Pharm Res. 1987 Aug; 4(4):311-6. PMID: 3508537.
      View in: PubMed
    16. Lee TY, Notari RE. Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure. Pharm Res. 1987 Apr; 4(2):98-103. PMID: 3334413.
      View in: PubMed
    17. Pejaver SK, Notari RE. Decreased stability in liposomal suspensions: accelerated loss of p-nitrophenyl acetate. J Pharm Sci. 1985 Nov; 74(11):1167-71. PMID: 4087176.
      View in: PubMed
    18. Notari RE. Theory and practice of prodrug kinetics. Methods Enzymol. 1985; 112:309-23. PMID: 4046852.
      View in: PubMed
    19. Kirsch LE, Notari RE. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine. J Pharm Sci. 1984 Jul; 73(7):896-902. PMID: 6206222.
      View in: PubMed
    20. Kirsch LE, Notari RE. Theoretical basis for the detection of general-base catalysis in the presence of predominating hydroxide catalysis. J Pharm Sci. 1984 Jun; 73(6):724-7. PMID: 6737254.
      View in: PubMed
    21. Kirsch LE, Notari RE. Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine. J Pharm Sci. 1984 Jun; 73(6):728-32. PMID: 6204036.
      View in: PubMed
    22. D'Silva JB, Notari RE. Drug stability in liposomal suspensions: hydrolysis of indomethacin, cyclocytidine, and p-nitrophenyl acetate. J Pharm Sci. 1982 Dec; 71(12):1394-8. PMID: 6185667.
      View in: PubMed
    23. Byron PR, Guest RT, Notari RE. Thermodynamic dependence of interfacial transfer kinetics of nonionized barbituric acid derivatives in two-phase transfer cell. J Pharm Sci. 1981 Nov; 70(11):1265-9. PMID: 7299674.
      View in: PubMed
    24. Notari RE. Prodrug design. Pharmacol Ther. 1981; 14(1):25-53. PMID: 7033999.
      View in: PubMed
    25. Tomlinson E, Notari RE, Byron PR. Simultaneous partitioning and hydrolysis kinetics of amoxicillin and ampicillin. J Pharm Sci. 1980 Jun; 69(6):655-8. PMID: 7205576.
      View in: PubMed
    26. Byron PR, Notari RE, Tomlinson E. Calculation of partition coefficient of an unstable compound using kinetic methods. J Pharm Sci. 1980 May; 69(5):527-31. PMID: 7381736.
      View in: PubMed
    27. D'Silva JB, Notari RE. Stability-indicating colorimetric assay for indicine N-oxide using TLC. J Pharm Sci. 1980 Apr; 69(4):471-2. PMID: 7373551.
      View in: PubMed
    28. Byron PR, Notari RE, Tomlinson E. Calculation of the partition coefficient of an unstable compound using kinetic methods [proceedings]. J Pharm Pharmacol. 1978 Dec; 30 Suppl:7P. PMID: 32328.
      View in: PubMed
    29. Byron PR, Notari RE. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model. J Pharm Sci. 1976 Aug; 65(8):1140-4. PMID: 978432.
      View in: PubMed
    30. Reuning RH, Malspeis L, Frank S, Notari RE. Testing of drug delivery systems for use in the treatment of narcotic addiction. Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan; (4):43-5. PMID: 823438.
      View in: PubMed
    31. Notari RE, DeYoung JL. Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions. J Pharm Sci. 1975 Jul; 64(7):1148-57. PMID: 50433.
      View in: PubMed
    32. Reuning RH, Malspeis L, Frank S, Notari RE. Testing of drug delivery systems for use in the treatment of narcotic addiction. Natl Inst Drug Abuse Res Monogr Ser. 1975; (4):43-5. PMID: 827709.
      View in: PubMed
    33. Notari RE, Kavaliunas DR, Bockbrader HN. Proceedings: Apparent biological half-life values determined by administration of drug by methods other than rapid intravenous injection. J Pharm Pharmacol. 1974 Dec; 26 Suppl:62P-63P. PMID: 4156741.
      View in: PubMed
    34. Notari RE. Proceedings: Structural effects in pharmacokinetics and drug response. Acta Pharm Suec. 1974 Dec; 11(6):633-5. PMID: 1136785.
      View in: PubMed
    35. DeYoung JL, Notari RE, Feller DR. Comparative reactivity of cytidine and arabinosylcytosine to their 6-methyl derivatives in the presence of cytidine deaminase. Res Commun Chem Pathol Pharmacol. 1974 Sep; 9(1):163-72. PMID: 4474681.
      View in: PubMed
    36. Garry PJ, Prince LC, Notari RE. Half-life of human serum cholinesterase following blood transfusion. Res Commun Chem Pathol Pharmacol. 1974 Jun; 8(2):371-80. PMID: 4852217.
      View in: PubMed
    37. Notari RE. Pharmacokinetics and molecular modification: implications in drug design and evaluation. J Pharm Sci. 1973 Jun; 62(6):865-81. PMID: 4576424.
      View in: PubMed
    38. Reuning RH, Sams RA, Notari RE. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. J Clin Pharmacol New Drugs. 1973 Apr; 13(4):127-41. PMID: 4487163.
      View in: PubMed
    39. Notari RE, Witiak DT, DeYoung JL, Lin AJ. Comparative kinetics of cytosine nucleosides. Influence of a 6-methyl substituent on degradation rates and pathways in aqueous buffers. J Med Chem. 1972 Dec; 15(12):1207-14. PMID: 4635962.
      View in: PubMed
    40. Notari RE, Chin ML, Wittebort R. Arabinosylcytosine stability in aqueous solutions: pH profile and shelflife predictions. J Pharm Sci. 1972 Aug; 61(8):1189-96. PMID: 5050364.
      View in: PubMed
    41. Notari RE, Baker T. Hydroxamic acids. IV. Hydroxide effect in hydroxylaminolysis of ethyl acetate. J Pharm Sci. 1972 Feb; 61(2):244-8. PMID: 5059791.
      View in: PubMed
    42. Notari RE, DeYoung JL, Reuning RH. Effect of parallel first-order loss from site of administration on calculated values for absorption rate constants. J Pharm Sci. 1972 Jan; 61(1):135-8. PMID: 5058633.
      View in: PubMed
    43. Notari RE, Chin ML, Cardoni A. Intermolecular and intramolecular catalysis in deamination of cytosine nucleosides. J Pharm Sci. 1970 Jan; 59(1):27-32. PMID: 5411321.
      View in: PubMed
    44. Notari RE, Caiola SM. Catalysis of streptovitacin A dehydration: kinetics and mechanisms. J Pharm Sci. 1969 Oct; 58(10):1203-8. PMID: 5349103.
      View in: PubMed
    45. Notari RE, Chin ML, Cardoni A. Intramolecular participation in the hydrolytic deamination of 1-beta-D-arabinosylcytosine. Tetrahedron Lett. 1969 Sep; (40):3499-502. PMID: 5820945.
      View in: PubMed
    46. Notari RE, Munson JW. Hydroxamic acids. I. Factors affecting the stability of the hydroxamic acid-iron complex. J Pharm Sci. 1969 Sep; 58(9):1060-4. PMID: 5346065.
      View in: PubMed
    47. Notari RE. Hydroxamic acids. II. Kinetics and mechanisms of hydroxyaminolysis of succinimide. J Pharm Sci. 1969 Sep; 58(9):1064-8. PMID: 5346066.
      View in: PubMed
    48. Notari RE. Hydroxamic acids. 3. Kinetics of acetohydroxamic acid formation from ethyl acetate. J Pharm Sci. 1969 Sep; 58(9):1069-73. PMID: 5346067.
      View in: PubMed
    49. Notari RE. A mechanism for the hydrolytic deamination of cytosine arabinoside in aqueous buffer. J Pharm Sci. 1967 Jul; 56(7):804-9. PMID: 6034820.
      View in: PubMed
    50. Garrett ER, Notari RE. Cycloheximide transformations. I. Kinetics and mechanisms in aqueous acid. J Org Chem. 1966 Feb; 31(2):425-34. PMID: 5902474.
      View in: PubMed
    51. Notari RE, Sokoloski TD. Kinetics of calcium carbonate neutralization. First-order case of the cube-root law. J Pharm Sci. 1965 Oct; 54(10):1500-4. PMID: 5883225.
      View in: PubMed
    52. Garrett ER, Notari RE. Determination of cycloheximide and its degradiation products alone and in mixtures. J Pharm Sci. 1965 Apr; 54(4):561-4. PMID: 5842339.
      View in: PubMed
    53. GARRETT ER, NOTARI RE. CYCOLHEXIMIDE TRANSFORMATIONS. II. KINETICS AND STABILITY IN A PHARMACEUTICALLY USEFUL PH RANGE. J Pharm Sci. 1965 Feb; 54:209-15. PMID: 14301000.
      View in: PubMed
    Notari's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description